Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Joubert

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Diabetologia|November 17, 2025
Artificial intelligence-driven clinical decision support systems to assist healthcare professionals and people with diabetes in Europe at the point of care: a Delphi-based consensus roadmapMia Bajramagic, Tadej Battelino, Xavier Cos, et al.
The Lancet. Diabetes & Endocrinology|February 26, 2026
Tubeless automated insulin delivery versus multiple daily injections in children and adults with type 1 diabetes with elevated HbA<sub>1c</sub> (RADIANT): a multicentre, international, parallel-group, open-label, randomised, controlled trialEmma G Wilmot, Jacques Beltrand, Bruno Guerci, et al.
Diabetes, Obesity & Metabolism|November 25, 2025
A nationwide 12-month observatory of automated insulin delivery shows improved glucose control, sustained adoption, and reduced acute severe eventsJean-Pierre Riveline, Jean-Baptiste Julla, Elisabeth Bonnemaison, et al.
Diabetes Technology & Therapeutics|July 10, 2026
Sustained Follow-up of Automated Insulin Delivery in a Real-World Setting: Results at 2 Years of the French Nationwide Observatory OB2FJean-Baptiste Julla, Chloé Amouyal, Sandrine Lablanche, et al.
The Lancet. Digital Health|December 16, 2020
Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trialPierre-Yves Benhamou, Sylvia Franc, Yves Reznik, et al.
Diabetologia|May 23, 2024
Heterogeneity of glycaemic phenotypes in type 1 diabetesGuy Fagherazzi, Gloria A Aguayo, Lu Zhang, et al.
Journal of Diabetes Science and Technology|February 12, 2025
Expert Clinical Interpretation of Continuous Glucose Monitor Reports From Individuals Without DiabetesNicole L Spartano, Brenton Prescott, Maura E Walker, et al.
Diabetes & Metabolism|December 14, 2020
Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19Jean-Daniel Lalau, Abdallah Al-Salameh, Samy Hadjadj, et al.
Diabetologia|May 31, 2020
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO studyBertrand Cariou, Samy Hadjadj, Matthieu Wargny, et al.
Diabetologia|July 4, 2020
Correction to: Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO studyBertrand Cariou, Samy Hadjadj, Matthieu Wargny, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Diabetologia|November 17, 2025
Artificial intelligence-driven clinical decision support systems to assist healthcare professionals and people with diabetes in Europe at the point of care: a Delphi-based consensus roadmapMia Bajramagic, Tadej Battelino, Xavier Cos, et al.
The Lancet. Diabetes & Endocrinology|February 26, 2026
Tubeless automated insulin delivery versus multiple daily injections in children and adults with type 1 diabetes with elevated HbA<sub>1c</sub> (RADIANT): a multicentre, international, parallel-group, open-label, randomised, controlled trialEmma G Wilmot, Jacques Beltrand, Bruno Guerci, et al.
Diabetes, Obesity & Metabolism|November 25, 2025
A nationwide 12-month observatory of automated insulin delivery shows improved glucose control, sustained adoption, and reduced acute severe eventsJean-Pierre Riveline, Jean-Baptiste Julla, Elisabeth Bonnemaison, et al.
Diabetes Technology & Therapeutics|July 10, 2026
Sustained Follow-up of Automated Insulin Delivery in a Real-World Setting: Results at 2 Years of the French Nationwide Observatory OB2FJean-Baptiste Julla, Chloé Amouyal, Sandrine Lablanche, et al.
The Lancet. Digital Health|December 16, 2020
Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trialPierre-Yves Benhamou, Sylvia Franc, Yves Reznik, et al.
Diabetologia|May 23, 2024
Heterogeneity of glycaemic phenotypes in type 1 diabetesGuy Fagherazzi, Gloria A Aguayo, Lu Zhang, et al.
Journal of Diabetes Science and Technology|February 12, 2025
Expert Clinical Interpretation of Continuous Glucose Monitor Reports From Individuals Without DiabetesNicole L Spartano, Brenton Prescott, Maura E Walker, et al.
Diabetes & Metabolism|December 14, 2020
Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19Jean-Daniel Lalau, Abdallah Al-Salameh, Samy Hadjadj, et al.
Diabetologia|May 31, 2020
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO studyBertrand Cariou, Samy Hadjadj, Matthieu Wargny, et al.
Diabetologia|July 4, 2020
Correction to: Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO studyBertrand Cariou, Samy Hadjadj, Matthieu Wargny, et al.
Pageof 8